Pomanda estimates the enterprise value of CIRCASSIA PHARMA LIMITED at £2.5m based on a Turnover of £2.6m and 0.93x industry multiple (adjusted for size and gross margin).
circassia pharma limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of CIRCASSIA PHARMA LIMITED at £0 based on an EBITDA of £0 and a 3.72x industry multiple (adjusted for size and gross margin).
circassia pharma limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of CIRCASSIA PHARMA LIMITED at £0 based on Net Assets of £-2.3m and 1.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Circassia Pharma LimitedOverview
Circassia Pharma Limited is a dissolved company that was located in oxford, OX4 4GA with a Companies House number of 06410308. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in October 2007, it's largest shareholder was
circassia pharmaceuticals plc
with a 100% stake. The last turnover for Circassia Pharma Limited was estimated at £2.6m.
Pomanda's financial health check has awarded Circassia Pharma Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
3 Strong
2 Regular
2 Weak
Size
annual sales of £2.6m, make it in line with the average company (£2.7m)
£2.6m - Circassia Pharma Limited
£2.7m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Circassia Pharma Limited
- - Industry AVG
Production
with a gross margin of 28.9%, this company has a higher cost of product (50.7%)
28.9% - Circassia Pharma Limited
50.7% - Industry AVG
Profitability
an operating margin of 0% make it more profitable than the average company (-3.3%)
0% - Circassia Pharma Limited
-3.3% - Industry AVG
Employees
with 12 employees, this is below the industry average (35)
12 - Circassia Pharma Limited
35 - Industry AVG
Pay Structure
on an average salary of £67.7k, the company has an equivalent pay structure (£67.7k)
£67.7k - Circassia Pharma Limited
£67.7k - Industry AVG
Efficiency
resulting in sales per employee of £220.2k, this is more efficient (£111.2k)
£220.2k - Circassia Pharma Limited
£111.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Circassia Pharma Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 444 days, this is slower than average (47 days)
444 days - Circassia Pharma Limited
47 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Circassia Pharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Circassia Pharma Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Circassia Pharma Limited
- - Industry AVG
CIRCASSIA PHARMA LIMITED financials
EXPORT
Circassia Pharma Limited's latest turnover from December 2018 is estimated at £2.6 million and the company has net assets of -£2.3 million. According to their latest financial statements, we estimate that Circassia Pharma Limited has 12 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
2,642,830
2,590,246
17,000
289,636
66,885
6,088
Other Income Or Grants
Cost Of Sales
1,880,036
1,827,421
216,012
50,788
4,519
Gross Profit
762,794
762,825
17,000
73,625
16,096
1,569
Admin Expenses
762,794
688,450
3,000
295,000
540,167
516,675
48,676
362,317
Operating Profit
74,375
17,000
-3,000
-295,000
-466,542
-500,579
-47,107
-362,317
Interest Payable
74,360
32,079
Interest Receivable
Pre-Tax Profit
15
17,000
-3,000
-295,000
-466,542
-500,579
-79,186
-362,317
Tax
-3
-1,000
1,000
26,000
Profit After Tax
12
17,000
-1,000
-2,000
-269,000
-466,542
-500,579
-79,186
-362,317
Dividends Paid
Retained Profit
12
17,000
-1,000
-2,000
-269,000
-466,542
-500,579
-79,186
-362,317
Employee Costs
812,392
728,439
106,551
53,653
51,809
Number Of Employees
12
12
1
1
1
1
2
1
1
EBITDA*
74,375
17,000
-3,000
-188,000
-466,542
-500,579
-47,107
-362,317
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
Intangible Assets
106,791
106,791
106,791
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
106,791
106,791
106,791
Stock & work in progress
Trade Debtors
1,000
27,000
104,384
17,215
1
Group Debtors
1
Misc Debtors
Cash
misc current assets
total current assets
1,000
27,000
104,384
17,215
1
1
total assets
1,000
27,000
211,175
124,006
106,792
1
Bank overdraft
Bank loan
Trade Creditors
2,287,988
2,287,988
21,000
154,330
84,749
34,630
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
2,287,988
2,287,988
21,000
154,330
84,749
34,630
loans
2,288,000
2,305,000
2,305,000
987,031
hp & lease commitments
Accruals and Deferred Income
other liabilities
2,308,000
2,090,182
1,606,052
1,138,378
provisions
total long term liabilities
2,288,000
2,305,000
2,305,000
2,308,000
2,090,182
1,606,052
1,138,378
987,031
total liabilities
2,287,988
2,287,988
2,288,000
2,305,000
2,305,000
2,329,000
2,244,512
1,690,801
1,173,008
987,031
net assets
-2,287,988
-2,287,988
-2,288,000
-2,305,000
-2,304,000
-2,302,000
-2,033,337
-1,566,795
-1,066,216
-987,030
total shareholders funds
-2,287,988
-2,287,988
-2,288,000
-2,305,000
-2,304,000
-2,302,000
-2,033,337
-1,566,795
-1,066,216
-987,030
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
74,375
17,000
-3,000
-295,000
-466,542
-500,579
-47,107
-362,317
Depreciation
Amortisation
107,000
Tax
-3
-1,000
1,000
26,000
Stock
Debtors
-1,000
-26,000
-77,384
87,169
17,214
1
Creditors
2,287,988
-21,000
-133,330
69,581
50,119
34,630
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
2,362,360
17,000
3,000
-217,946
-484,130
-467,674
-12,477
-362,318
Investing Activities
capital expenditure
-209
-106,791
Change in Investments
cash flow from investments
-209
-106,791
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
-2,288,000
-17,000
2,305,000
-987,031
987,031
Hire Purchase and Lease Commitments
other long term liabilities
-2,308,000
217,818
484,130
467,674
1,138,378
share issue
337
-624,713
interest
-74,360
-32,079
cash flow from financing
-2,362,360
-17,000
-3,000
218,155
484,130
467,674
119,268
362,318
cash and cash equivalents
cash
overdraft
change in cash
circassia pharma limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for circassia pharma limited. Get real-time insights into circassia pharma limited's credit score, group structure and payment trends.
Perform a competitor analysis for circassia pharma limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in OX4 area or any other competitors across 12 key performance metrics.
circassia pharma limited Ownership
CIRCASSIA PHARMA LIMITED group structure
Circassia Pharma Limited has no subsidiary companies.
the magdalen centre, robert robinson avenue, oxford, oxfordshire, OX4 4GA
Bank
HSBC BANK PLC
Legal Advisor
-
circassia pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to circassia pharma limited.
circassia pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CIRCASSIA PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
circassia pharma limitedCompanies House Filings - See Documents
